IVIG enters the central nervous system during treatment of experimental autoimmune encephalomyelitis and is localised to inflammatory lesions

By Jorgensen Signe   Storm Nicolas   Jensen Poul   Laursen Henning   Sorensen Per  

Experimental Brain Research, Vol. 178, Iss. 4, 2007-04 ,pp. : 462-469

Springer Publishing Company

Access to resources Recommend Favorite

Gene expression profiling of the nervous system in murine experimental autoimmune encephalomyelitis

By Ibrahim S.M.  

Brain, Vol. 124, Iss. 10, 2001-10 ,pp. : 1927-1938

Oxford University Press

Access to resources Recommend Favorite

Suppression of Experimental Autoimmune Encephalomyelitis by Tyrphostin AG-556

By Brenner T.   Poradosu E.   Soffer D.   Sicsic C.   Gazit A.   Levitzki A.  

Experimental Neurology, Vol. 154, Iss. 2, 1998-12 ,pp. : 489-498

Elsevier

Access to resources Recommend Favorite

Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis

By Pomeroy Ian M.   Matthews Paul M.   Frank Joseph A.   Jordan Elaine K.   Esiri Margaret M.  

Brain, Vol. 128, Iss. 11, 2005-11 ,pp. : 2713-2721

Oxford University Press

Access to resources Recommend Favorite

Fibrinogen Depleting Agent Batroxobin has a Beneficial Effect on Experimental Autoimmune Encephalomyelitis

By Yang Yang   Tian Shu-juan   Wu Lei   Huang De-hui   Wu Wei-ping  

Cellular and Molecular Neurobiology, Vol. 31, Iss. 3, 2011-04 ,pp. : 437-448

Springer Publishing Company

Access to resources Recommend Favorite